Global Gastrointestinal Therapeutics Market Report

1. Global Gastrointestinal Therapeutics Market Research Report
1. 1.1 Study Objectives
2. 1.2 Global Gastrointestinal Therapeutics Market - Overview
3. 1.3 Reason to Read This Report
4. 1.4 Methodology and Forecast Analysis
2. Global Gastrointestinal Therapeutics Market Research Report - Preface
1. 2.1 Global Gastrointestinal Therapeutics Market Research Report – Detailed Scope and Definitions
1. 2.1.1 By Drug Class
2. 2.1.2 By Indication
3. 2.1.3 By End User
4. 2.1.4 By Region
3. Global Gastrointestinal Therapeutics Market Dynamics
1. 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
2. 3.2. Restraints – By Drug Class, By Indication, By End User, By Country
3. 3.3. Opportunities – By Drug Class, By Indication, By End User, By Country
4. 3.4. Trends – By Drug Class, By Indication, By End User, By Country
5. 3.5. PEST Analysis
6. 3.6. Porters Five Rule Analysis
7. 3.7. Company’s Share Analysis (CSA) by Region or By Country
8. 3.8. Global Gastrointestinal Therapeutics Market Research Report – DROTs Impact Analysis
4. Global Gastrointestinal Therapeutics Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
1. 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
3. 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
4. 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
5. Global Gastrointestinal Therapeutics Market, By Drug Class, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
1. 5.1 Aminosalicylates
1. 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
2. 5.2 Antacids
1. 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
3. 5.3 Antidiarrheals
1. 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
4. 5.4 Antiemetics
1. 5.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 5.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 5.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 5.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
5. 5.5 Antiulcer Agents
1. 5.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 5.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 5.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 5.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
6. 5.6 Biologics
1. 5.6.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 5.6.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 5.6.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 5.6.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
7. 5.7 Laxatives
1. 5.7.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 5.7.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 5.7.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 5.7.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
8. 5.8 Proton Pump Inhibitors (PPIs)
1. 5.8.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 5.8.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 5.8.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 5.8.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
9. 5.9 H2 Receptor Antagonists
1. 5.9.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 5.9.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 5.9.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 5.9.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
10. 5.10 Prokinetics
1. 5.10.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 5.10.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 5.10.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 5.10.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
11. 5.11 Antibiotics
1. 5.11.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 5.11.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 5.11.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 5.11.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
6. Global Gastrointestinal Therapeutics Market, By Indication, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
1. 6.1 Gastroesophageal Reflux Disease (GERD)
1. 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
2. 6.2 Peptic Ulcer Disease
1. 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
3. 6.3 Irritable Bowel Syndrome (IBS)
1. 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
4. 6.4 Inflammatory Disease (IBD)
1. 6.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 6.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 6.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 6.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
5. 6.5 Diarrhea
1. 6.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 6.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 6.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 6.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
6. 6.6 Constipation
1. 6.6.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 6.6.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 6.6.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 6.6.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
7. 6.7 Nausea and Vomiting
1. 6.7.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 6.7.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 6.7.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 6.7.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
8. 6.8 Celiac Disease
1. 6.8.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 6.8.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 6.8.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 6.8.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
9. 6.9 Others
1. 6.9.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 6.9.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 6.9.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 6.9.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
7. Global Gastrointestinal Therapeutics Market, By End User, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
1. 7.1 Hospitals
1. 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
2. 7.2 Clinics
1. 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
3. 7.3 Homecare Settings
1. 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
4. 7.4 Ambulatory Surgical Centers.
1. 7.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 7.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 7.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 7.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
8. Global Gastrointestinal Therapeutics Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn)
1. 8.1 North America
   1. 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
   2. 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
   3. 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
   4. 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
2. 8.2 Europe
   1. 8.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
   2. 8.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
   3. 8.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
   4. 8.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
3. 8.3 Asia-Pacific
   1. 8.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
   2. 8.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
   3. 8.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
   4. 8.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
4. 8.4 Latin America
   1. 8.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
   2. 8.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
   3. 8.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
   4. 8.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
5. 8.5 Middle East & Africa
   1. 8.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
   2. 8.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
   3. 8.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
   4. 8.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
8.6 Global Gastrointestinal Therapeutics Market - Opportunity Analysis Index, By Drug Class, By Indication, By End User, and Region, 2024 - 2031
9. North America Global Gastrointestinal Therapeutics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
9.1 By Drug Class Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 9.1.1 Aminosalicylates
2. 9.1.2 Antacids
3. 9.1.3 Antidiarrheals
4. 9.1.4 Antiemetics
5. 9.1.5 Antiulcer Agents
6. 9.1.6 Biologics
7. 9.1.7 Laxatives
8. 9.1.8 Proton Pump Inhibitors (PPIs)
9. 9.1.9 H2 Receptor Antagonists
10. 9.1.10 Prokinetics
11. 9.1.11 Antibiotics
9.2 By Indication Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 9.2.1 Gastroesophageal Reflux Disease (GERD)
2. 9.2.2 Peptic Ulcer Disease
3. 9.2.3 Irritable Bowel Syndrome (IBS)
4. 9.2.4 Inflammatory Disease (IBD)
5. 9.2.5 Diarrhea
6. 9.2.6 Constipation
7. 9.2.7 Nausea and Vomiting
8. 9.2.8 Celiac Disease
9. 9.2.9 Others
9.3 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 9.3.1 Hospitals
2. 9.3.2 Clinics
3. 9.3.3 Homecare Settings
4. 9.3.4 Ambulatory Surgical Centers.
9.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 9.4.1 United States
2. 9.4.2 Canada
9.5 North America Global Gastrointestinal Therapeutics Market – Opportunity Analysis Index, By Drug Class, By Indication, By End User, and Country, 2024 - 2031
9.6 Regional Trends Analysis
9.7 North America Global Gastrointestinal Therapeutics Market Research Report - Company Profiles
1. 9.7.1 Company 1 (United States)
2. 9.7.2 Company 2 (Canada)
3. 9.7.3 Company 3 (Canada)
10. Europe Global Gastrointestinal Therapeutics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
10.1 By Drug Class Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 10.1.1 Aminosalicylates
2. 10.1.2 Antacids
3. 10.1.3 Antidiarrheals
4. 10.1.4 Antiemetics
5. 10.1.5 Antiulcer Agents
6. 10.1.6 Biologics
7. 10.1.7 Laxatives
8. 10.1.8 Proton Pump Inhibitors (PPIs)
9. 10.1.9 H2 Receptor Antagonists
10. 10.1.10 Prokinetics
11. 10.1.11 Antibiotics
10.2 By Indication Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 10.2.1 Gastroesophageal Reflux Disease (GERD)
2. 10.2.2 Peptic Ulcer Disease
3. 10.2.3 Irritable Bowel Syndrome (IBS)
4. 10.2.4 Inflammatory Disease (IBD)
5. 10.2.5 Diarrhea
6. 10.2.6 Constipation
7. 10.2.7 Nausea and Vomiting
8. 10.2.8 Celiac Disease
9. 10.2.9 Others
10.3 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 10.3.1 Hospitals
2. 10.3.2 Clinics
3. 10.3.3 Homecare Settings
4. 10.3.4 Ambulatory Surgical Centers.
10.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 10.4.1 Germany
2. 10.4.2 United Kingdom
3. 10.4.3 France
4. 10.4.4 Spain
5. 10.4.5 Italy
6. 10.4.6 Russia
7. 10.4.7 Netherlands
8. 10.4.8 Poland
9. 10.4.9 Rest of Europe
10.5 Europe Global Gastrointestinal Therapeutics Market – Opportunity Analysis Index, By Drug Class, By Indication, By End User, and Country, 2024 - 2031
10.6 Regional Trends Analysis
10.7 Europe Global Gastrointestinal Therapeutics Market Research Report - Company Profiles
1. 10.7.1 Company 1 (Germany)
2. 10.7.2 Company 2 (United Kingdom)
3. 10.7.3 Company 3 (United Kingdom)
11. Asia-Pacific Global Gastrointestinal Therapeutics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
11.1 By Drug Class Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 11.1.1 Aminosalicylates
2. 11.1.2 Antacids
3. 11.1.3 Antidiarrheals
4. 11.1.4 Antiemetics
5. 11.1.5 Antiulcer Agents
6. 11.1.6 Biologics
7. 11.1.7 Laxatives
8. 11.1.8 Proton Pump Inhibitors (PPIs)
9. 11.1.9 H2 Receptor Antagonists
10. 11.1.10 Prokinetics
11. 11.1.11 Antibiotics
11.2 By Indication Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 11.2.1 Gastroesophageal Reflux Disease (GERD)
2. 11.2.2 Peptic Ulcer Disease
3. 11.2.3 Irritable Bowel Syndrome (IBS)
4. 11.2.4 Inflammatory Disease (IBD)
5. 11.2.5 Diarrhea
6. 11.2.6 Constipation
7. 11.2.7 Nausea and Vomiting
8. 11.2.8 Celiac Disease
9. 11.2.9 Others
11.3 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 11.3.1 Hospitals
2. 11.3.2 Clinics
3. 11.3.3 Homecare Settings
4. 11.3.4 Ambulatory Surgical Centers.
11.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 11.4.1 China
2. 11.4.2 Japan
3. 11.4.3 India
4. 11.4.4 South Korea
5. 11.4.5 Australia & NZ
6. 11.4.6 ASEAN
7. 11.4.7 Rest of Asia-Pacific
11.5 Asia-Pacific Global Gastrointestinal Therapeutics Market – Opportunity Analysis Index, By Drug Class, By Indication, By End User, and Country, 2024 - 2031
11.6 Regional Trends Analysis
11.7 Asia-Pacific Global Gastrointestinal Therapeutics Market Research Report - Company Profiles
1. 11.7.1 Company 1 (China)
2. 11.7.2 Company 2 (Japan)
3. 11.7.3 Company 3 (Japan)
12. Latin America Global Gastrointestinal Therapeutics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
12.1 By Drug Class Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 12.1.1 Aminosalicylates
2. 12.1.2 Antacids
3. 12.1.3 Antidiarrheals
4. 12.1.4 Antiemetics
5. 12.1.5 Antiulcer Agents
6. 12.1.6 Biologics
7. 12.1.7 Laxatives
8. 12.1.8 Proton Pump Inhibitors (PPIs)
9. 12.1.9 H2 Receptor Antagonists
10. 12.1.10 Prokinetics
11. 12.1.11 Antibiotics
12.2 By Indication Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 12.2.1 Gastroesophageal Reflux Disease (GERD)
2. 12.2.2 Peptic Ulcer Disease
3. 12.2.3 Irritable Bowel Syndrome (IBS)
4. 12.2.4 Inflammatory Disease (IBD)
5. 12.2.5 Diarrhea
6. 12.2.6 Constipation
7. 12.2.7 Nausea and Vomiting
8. 12.2.8 Celiac Disease
9. 12.2.9 Others
12.3 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 12.3.1 Hospitals
2. 12.3.2 Clinics
3. 12.3.3 Homecare Settings
4. 12.3.4 Ambulatory Surgical Centers.
12.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 12.4.1 Brazil
2. 12.4.2 Mexico
3. 12.4.3 Argentina
4. 12.4.4 Peru
5. 12.4.5 Colombia
6. 12.4.6 Rest of Latin America
12.5 Latin America Global Gastrointestinal Therapeutics Market – Opportunity Analysis Index, By Drug Class, By Indication, By End User, and Country, 2024 - 2031
12.6 Regional Trends Analysis
12.7 Latin America Global Gastrointestinal Therapeutics Market Research Report - Company Profiles
1. 12.7.1 Company 1 (Brazil)
2. 12.7.2 Company 2 (Mexico)
3. 12.7.3 Company 3 (Mexico)
13. Middle East & Africa Global Gastrointestinal Therapeutics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
13.1 By Drug Class Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 13.1.1 Aminosalicylates
2. 13.1.2 Antacids
3. 13.1.3 Antidiarrheals
4. 13.1.4 Antiemetics
5. 13.1.5 Antiulcer Agents
6. 13.1.6 Biologics
7. 13.1.7 Laxatives
8. 13.1.8 Proton Pump Inhibitors (PPIs)
9. 13.1.9 H2 Receptor Antagonists
10. 13.1.10 Prokinetics
11. 13.1.11 Antibiotics
13.2 By Indication Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 13.2.1 Gastroesophageal Reflux Disease (GERD)
2. 13.2.2 Peptic Ulcer Disease
3. 13.2.3 Irritable Bowel Syndrome (IBS)
4. 13.2.4 Inflammatory Disease (IBD)
5. 13.2.5 Diarrhea
6. 13.2.6 Constipation
7. 13.2.7 Nausea and Vomiting
8. 13.2.8 Celiac Disease
9. 13.2.9 Others
13.3 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 13.3.1 Hospitals
2. 13.3.2 Clinics
3. 13.3.3 Homecare Settings
4. 13.3.4 Ambulatory Surgical Centers.
13.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 13.4.1 Saudi Arabia
2. 13.4.2 UAE
3. 13.4.3 South Africa
4. 13.4.4 Egypt
5. 13.4.5 Israel
6. 13.4.6 Rest of Middle East and Africa
13.5 Middle East & Africa Global Gastrointestinal Therapeutics Market – Opportunity Analysis Index, By Drug Class, By Indication, By End User, and Country, 2024 - 2031
13.6 Regional Trends Analysis
13.7 Middle East & Africa Global Gastrointestinal Therapeutics Market Research Report - Company Profiles
1. 13.7.1 Company 1 (Saudi Arabia)
2. 13.7.2 Company 2 (UAE)
3. 13.7.3 Company 3 (UAE)
14. Competition Landscape
14.1 Strategic Dashboard of Top Market Players
14.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)

1. 14.2.1 AbbVie Inc.
2. 14.2.2 Takeda Pharmaceutical Company Limited
3. 14.2.3 Johnson & Johnson
4. 14.2.4 Pfizer Inc.
5. 14.2.5 GlaxoSmithKline plc
15. Data Collection Method and Research Approach
16. Principal Presumptions and Acronyms